SINOVAC Announces Decision to Declare Cash Dividend

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company’s board of directors (the “Board”) has decided to declare a special cash dividend of US$55.00 per common share (the “Dividend”). The Board expects to fund the Dividend from available cash resources of … [Read more…]

Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual Meeting of Shareholders

TORONTO–(BUSINESS WIRE)–Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that the Company has filed its management information circular (“Circular”) and related materials (together with the Circular, the “Meeting Materials”) for the annual meeting of shareholders (the “Shareholders”) of Jamieson Wellness to be held on May 27, 2025 at 2:00 p.m. (Eastern … [Read more…]

Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets

COLUMBUS, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (“Navidea” or the “Company”) today announced that its Board of Directors has elected to extend the Company’s Section 382 Rights Agreement (the “Section 382 Rights Plan”). Originally adopted on April 7, 2022, and set to expire on April 6, 2025, the plan has now been extended to April 7, 2027. … [Read more…]

Tranont Launches Clear: A Refreshing Twist on an Everyday, All-Day Protein Supplement for Women

New clear whey protein delivers 20g of fast-absorbing protein in a light, refreshing drink—without the thick, milky texture of traditional shakes LEHI, Utah–(BUSINESS WIRE)–#ClearProtein—Tranont introduces Clear, a new and easy way for women to supplement protein without the thick, milky texture of traditional shakes. Clear is designed to fuel muscle recovery, boost energy and keep … [Read more…]

eyonis™ LCS, Median Technologies’ AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study

All secondary endpoints required to support eyonis™ LCS’ intended use and desired marketing claims achieved in RELIVE eyonis™ LCS previously met primary endpoint, achieving statistically significant superiority compared to state of the art in RELIVE U.S. FDA 510(k) filing is on track for May 2025, and filing for CE marking expected in June 2025 Preparing … [Read more…]

LucyRx Marks Major Milestones, Unveils Bold Brand Identity to Break Through PBM Complexity and Champion Patient Care

BETHESDA, Md.–(BUSINESS WIRE)–#benefits–LucyRx, a next-generation pharmacy benefit manager (PBM) built on decades of leadership experience and committed to reimagining prescription care, has unveiled a bold brand identity as it surpasses significant growth milestones. Now serving more than one million members across 1,200 clients in all 50 states, LucyRx is delivering prescription care that puts patients … [Read more…]

Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management

BARCELONA, Spain–(BUSINESS WIRE)–#FerrerForGood–The seventh edition of the International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT), organized by the pharmaceutical company Ferrer, gathered over 150 experts in pulmonology and cardiology from more than 30 countries in Barcelona this past weekend. The event reaffirmed the clinical community’s commitment to multidisciplinary and international collaboration to improve the treatment … [Read more…]

Convatec Announces Exclusive Collaboration With Largest Wound, Ostomy and Continence Professional Nursing Organisation

Unique global programme and collaboration with Wound, Ostomy, and Continence Nurses Society™ (WOCN®) set to support healthcare professionals LONDON–(BUSINESS WIRE)–Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, is excited to announce its global collaboration with the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the largest and … [Read more…]

Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

SYDNEY–(BUSINESS WIRE)–#GIC–Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund. Novotech, headquartered … [Read more…]

Clinical Data Presented at ACC 2025 Shows Sensydia CPS™ Provides Accurate Assessment of Mean Pulmonary Artery Pressure Non-Invasively

— Non-invasive platform offers potential to transform heart failure care — — CPS on display for physicians in Sensydia booth #8029 at the American College of Cardiology (ACC) Annual Scientific Session & Expo — CHICAGO–(BUSINESS WIRE)–Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a … [Read more…]